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Executive Summary
This report sets out the findings from an investigation into the numbers of children and young 
people with life-limiting conditions in Scotland, and what current evidence tells us about their, 
and their families’, psychosocial support needs.
The overall purpose of the study was to develop an evidence base to support and inform planning 
for children’s palliative care in Scotland. It is hoped that the evidence generated will be a resource 
to organisations with responsibility for, or delivering services to, children and young people with 
life-limiting conditions.
The objectives of the research were as follows:
 n to identify the number of children and young people with life-limiting or life-threatening 
conditions in Scotland;
 n to describe this population in terms of their ages, conditions/diagnoses, geographic locations 
and ethnicity;
 n to generate evidence on their psychosocial care needs.
The study comprised two workstreams. First, and achieved by a complex process of linking 
national administrative and health services datasets, an analysis of population level data in order 
to describe the numbers and characteristics of children and young people with life-limiting or life-
threatening conditions in Scotland. Second, a detailed review of existing international evidence on 
children and young people’s, parents’ and siblings’ accounts of living with a life-limiting or life-
threatening condition, and their perceived psychosocial support needs.
Based on the findings, the research team has made ten recommendations. Five arise from the 
evidence concerning the numbers of children and young people in Scotland who have a life-
limiting condition. The remainder are based on the findings from the review of existing evidence. 
The recommendations are:
RECOMMENDATION 1: More children and young people of ALL AGES in Scotland with life-
limiting conditions should have input from palliative care services.
RECOMMENDATION 2: Children under 1 year of age should be seen as a priority group for 
input from palliative care services.
RECOMMENDATION 3: Age specific palliative care services for young people (aged 16-25 
years) with a life-limiting condition in Scotland should be developed.
RECOMMENDATION 4: Palliative care services should be able to provide culturally 
competent care to children and young people from ALL ethnic groups.
RECOMMENDATION 5: Future development of palliative care services in Scotland 
should ensure that access to services for children and young people from areas of high 
deprivation is prioritised.
RECOMMENDATION 6: Specialist psychological and emotional care should be available to 
children and young people and all family members. Included in this should be support for 
couples, and support and guidance to parents as they respond to the emotional needs of 
their children. Services caring for children and young people with life-limiting conditions 
should also find ways to provide opportunities for all family members to connect with 
and spend time with their ‘peers’. 
RECOMMENDATION 7: Palliative care services should consider incorporating domestic 
support to families within their portfolio of services. They should also seek ways to 
extend provision of support to parents in order to reduce, or provide a break from, the 
caring demands and responsibilities placed on parents. 
RECOMMENDATION 8: Palliative care services in Scotland should continue to include 
specialist residential provision. This provision should be extended in light of evidence of 
the size of the population of children with life-limiting conditions living in Scotland. 
RECOMMENDATION 9: Palliative care services should contribute to, or support activities 
which seek to, educate and challenge societal perceptions of impairment and disability.
RECOMMENDATION 10: Palliative care services, and other services involved in providing 
care at end of life, should examine current practices with respect to evidence on 
parents’ psychosocial needs as parents at their child’s end of life.
Paul Ham
pton
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Background and Context
Although many of the individual diagnoses are 
rare, as a group, children and young people 
with a life-limiting condition1 are a larger 
patient population than many other long term 
conditions in children and young people (e.g. 
diabetes mellitus (Royal College of Paediatrics 
and Child Health, 2014)). Previous work has 
shown that the prevalence of children and 
young people with a life-limiting condition 
in England is both rising and higher than 
previously estimated (Fraser et al., 2011, Fraser 
et al., 2012). 
The ChiSP Study
The ChiSP study (Children in Scotland requiring 
Palliative Care: identifying numbers and needs) 
was commissioned in order to provide an 
evidence base to inform the future planning 
and design of paediatric palliative care services 
in Scotland. It focused specifically on two 
areas of evidence: the numbers of children 
and young people with life-limiting conditions 
living in Scotland; and family members’ 
experiences and views regarding their 
psychosocial support needs. 
The study comprised two workstreams. 
Workstream 1 comprised secondary analysis 
of routinely collected healthcare and 
administrative data in order to describe 
the size of the population, as well as 
providing more detailed evidence on the 
characteristics of that population, including 
the stage of their condition. Workstream 
2 was a review of existing research which 
has explored, using methods such as 
interviews and focus groups, children and 
1Definition of terms
Life-limiting conditions are those for which 
there is no reasonable hope of cure and from 
which children or young people will ultimately 
die prematurely, e.g., Duchenne muscular 
dystrophy or neurodegenerative disease. 
Life-threatening conditions are those for which 
curative treatment may be feasible but can fail, 
e.g. cancer (Together for Short Lives, 2015). 
The term, ‘life-limiting condition’ will be used 
throughout this report to include both life-
limiting and life-threatening conditions.
young people’s, parents’ and siblings’ views 
of their psychosocial support needs. Details 
of the methods and datasets used by the 
workstreams are provided in the Appendices. 
The results (and their implications) from 
these two workstreams have resulted in 
ten recommendations regarding services 
for children and young people with life-
limiting conditions and their families. The 
recommendations are concerned with both 
supporting developments in services to ensure 
all families who may benefit from palliative 
care have access to such services, and 
the ‘content’ of such services – particularly 
meeting families’ psychosocial care and 
support needs. 
The following sections of the report present 
these recommendations within the context 
of the data, or findings, which informed 
them. Section 2 presents the evidence 
and recommendations arising from the 
epidemiological work (workstream 1). Section 
3 sets out the recommendations regarding 
psychosocial care and support to families, 
again nesting these within the evidence from 
which they were generated.
However, before moving on to present 
the recommendations, and the evidence 
underlying them, it is helpful to provide 
some information about the current context 
regarding paediatric palliative care in Scotland.
Paediatric Palliative Care in 
Scotland: the current context
In 2012, the Scottish Children and Young 
People’s Palliative Care Executive (SCYPPEx) 
published a framework for the delivery of 
palliative care for children and young people 
in Scotland. The definition of palliative care 
used in this report is: “…….. an active and total 
approach to care, from the point of diagnosis 
or recognition, embracing physical, emotional, 
social and spiritual elements through to death 
and beyond. It focuses on enhancement of 
quality of life for the child/young person 
and support for the family and includes 
the management of distressing symptoms, 
provision of short breaks and care through 
SECTION 1
death and bereavement” (Scottish Children 
and Young People’s Palliative Care Executive 
Group, 2012 Page 2). This framework aims to 
ensure that there are recognised pathways 
for palliative care for every child and young 
person from the point of diagnosis of a life-
limiting condition. The current provision of 
specialist paediatric palliative care services 
for children and young people in Scotland is 
shown in box below2.
Looking forwards, a report from the Scottish 
Public Health Network (ScotPHN) – Palliative 
and End of Life Care in Scotland:  
The Rationale for a Public Health Approach 
– will be published in late 2015. Additionally, 
the findings and recommendations from the 
Scottish Parliament’s enquiry into Palliative 
Care, as investigated by its Health and Sport 
Committee, are expected to acknowledge 
the importance of palliative care for all ages, 
including babies, children and young people. 
The Committee was made aware that the 
ChiSP study will also report in 2015, offering 
new information on the numbers and specific 
palliative care needs of individuals 0-25 years, 
as well as those of their families.
2Specialist paediatric palliative care services and posts in Scotland: the current picture 
Dr Pat Carragher, Medical Director to Children’s Hospice Association Scotland
Children’s palliative care is part of good medical care, and as such, it is delivered across primary, 
secondary and tertiary care, as well as in children’s hospices, but currently most end of life care is 
delivered in hospital environments. 
In Scotland, within the NHS there are relatively few care professionals who have children’s palliative care 
as a substantive part of their posts or who have undergone specialist post graduate training. Exceptions 
include NHS Arran and Ayrshire Health Board where there is a WellChild nursing team (with some specific 
palliative role in children with complex needs) and paediatrician with specialist qualifications and an interest 
in paediatric palliative care. In addition, 2015 saw a consultant neonatologist commencing work in a joint post 
between Children’s Hospice Association Scotland (CHAS) and NHS Lothian. A second joint consultant post is 
being developed between NHS Greater Glasgow and Clyde and CHAS, with the post holder having undertaken 
specialist training in oncology and haematology.
The Managed Service Network for Children and Young People with Cancer (MSNCYPC) employs a Consultant 
Paediatric Oncologist. This post specifically includes a palliative component (~1 day/week), and includes 
the remit of seeking to improve paediatric palliative care for children and young people across Scotland 
(primarily) with oncology and haematology diagnoses. Paediatric Palliative Outreach Nurses work specifically 
with children and young people with these same diagnoses during diagnosis, active treatment, palliative care 
and end of life care phases of children’s and young people’s lives. 
Children’s hospice services were first introduced in Scotland in 1996 when Rachel House opened. (Before 
this some parents took their children as far as Martin House in West Yorkshire to obtain specialist palliative 
care). CHAS now provides hospice services for babies, children and young people across all health board 
areas in Scotland. Holistic care is provided through its two hospices (Rachel House, and Robin House in 
Balloch), and via CHAS at Home. It is delivered by a multidisciplinary team including doctors, nurses, social 
workers, pharmacist, family support workers, as well as a full administrative team in order to provide 24/7 
support of its services. 
CHAS at Home has teams working from Inverness, Aberdeen, Kinross and Balloch to provide care in families’ 
homes. When required, they can also augment care in hospital. In 2014, a team of Diana Children’s Nurses was 
appointed to work across Scotland, with nurses working within NHS teams but managed and supported by 
CHAS. The aim of this nursing team is to further develop palliative care services and support for children, as 
well as their families, and to help improve choices in care. The team has both generic and specialist expertise 
with one nurse having a specific remit in intensive care and oncology, another in neonatology, and the other 
in community liaison.
In terms of transition to adult care there are different models across Scotland, but on a pan-Scotland basis, 
the SCYPPEx Framework states that “individual health boards should develop local pathways for transition of 
young people with palliative care needs to appropriate adult services” (Scottish Children’s and Young People’s 
Palliative Care Executive Group (2012, p23). Some specialities are more developed, as in oncology where 
the Cancer Plan for Children and Young People in Scotland 2012-15 (MSNCYPC) aims to offer seamless care 
for individuals up to the age of 25 years. This is based on strong cooperation between children’s and adult 
services, and is aided by the provision of facilities by the Teenage Cancer Trust.
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The numbers and characteristics 
of children and young people with 
life-limiting conditions in Scotland: 
findings and recommendations
Cohort identification
A previously developed (Fraser et al., 2011, 
Fraser et al., 2012) list of ICD10 (International 
Classification of Diseases, 10th edition (World 
Health Organisation, 1992)) codes that 
constituted the conditions of interest was 
utilised to identify individuals with a life-
limiting condition within routinely collected 
NHS data (Figure 1). The study cohort was 
identified by searching the Scottish Morbidity 
Record Inpatient activity database (SMR01) 
and Scottish Birth Records (SBR) for individuals 
resident in Scotland, aged 0-25 years, with 
any of the included ICD10 codes listed in any 
record from 1 April 2003 to 30 March 2014. 
Linkage to the other healthcare data for these 
individuals was then undertaken.
Introduction
This section sets out the recommendations, 
and supporting evidence, regarding the 
numbers and characteristics of children and 
young people with life-limiting conditions 
living in Scotland. Secondary analysis 
of routinely collected healthcare and 
administrative data was used to identify and 
describe the size of the population, as well 
as providing more detailed evidence on the 
characteristics of that population, including 
the stage of their condition.
Hospital 
based 
prevalence
Study cohort
Limit to 
individuals with 
LLC diagnosis 
between 1 April 
2003 and 
31 March 2014
Add records only 
for individuals in 
study cohort
Include only when 
aged 0–25 
and after first 
LLC diagnosis
Include only when 
aged 0–25 and after 
first LLC diagnosis
Inpatient data 
(SMR01)
Birth data 
(SBR)
PICANet Data 
(2007/08 
onwards)
Cancer 
register 
(SMR06)
GRO death 
register
Outpatient 
data (SMR00)
Study cohort with extra 
records from community 
prescriptions
Complete 
prevalenceCommunity 
prescribing 
data (2009/10 
onwards)
Study cohort with completed 
diagnostic categories, 
ethnicity, date of birth, date 
of death, gender, IMD(2009) 
and NHS board of residence.
FIGURE 1: Data sources used in the study . Dark blue boxes indicate sources of records used to identify 
individuals with a life-limiting condition; light blue box indicates source of records used to indicate presence 
of identified individuals in Scotland for complete prevalence analyses; light teal boxes indicate sources of 
demographic and date of death information; dark teal boxes indicate intermediate stages of combined 
datasets and grey boxes indicate final datasets used to determine prevalence figures . .
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FIGURE 2: Hospital-based and complete prevalence of life-limiting conditions among children and 
young people (aged 0-25 years) in Scotland for financial years 2003/4 – 2013/14 .  
Shaded regions indicate 95% confidence interval .
Prevalence analyses
Prevalence is a measure of the number 
of individuals with a given condition in a 
population at a given time (each financial year 
in this study). 
prevalence = number of individuals with a LLC  x 10000 
 population at risk
Two prevalence figures were used in this 
study. Firstly ‘hospital-based prevalence’ 
(Fraser et al., 2012) in which individuals were 
counted in a given year if they had a life-
limiting condition and any inpatient hospital 
episode (SBR or SMR01) in that year while 
aged 0-25 years. Under the second criteria 
(complete prevalence), all individuals counted 
using the first set of criteria were included 
and, in addition, individuals were counted if 
they appeared in the community prescribing 
records in that year (this indicated that they 
were still alive and resident in Scotland). 
As community prescribing data were only 
available from 2009 onwards, the complete 
prevalence analyses were limited to financial 
years 2009/2010 to 2013/2014.
Detailed methodology is available in 
Appendix 1. 
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FIGURE 3: Hospital-based and complete prevalence of life-limiting conditions by age group among 
children and young people in Scotland for financial years 2003/4 – 2013/14 .  
Shaded regions indicate 95% confidence interval .
Recommendation 1: 
More children and young people of ALL AGES in Scotland with life-
limiting conditions should have input from palliative care services
The evidence on prevalence
The prevalence of children and young people 
(aged 0-25 years) with a life-limiting condition 
in Scotland has risen markedly between 
2003/4 and 2013/14 (Figure 2). The hospital-
based prevalence had risen from 27.3 (95% CI 
26.9-27.7) per 10,000 population in 2003/4 to 
41.4 (95% CI 40.9-41.9) per 10,000 population 
in 2013/14 (Table 1, Figure 2). The complete 
prevalence estimates also includes children 
and young people with a life-limiting condition 
who are still alive and resident in Scotland 
but who had not received inpatient care in 
that year. These data also show a rise from a 
prevalence of from 75.0 (95% CI 74.3-75.7) per 
10,000 in 2009/10 to 95.7 (95% CI 94.9-96.5) 
per 10,000 in 2013/14.
The absolute numbers of children and young 
people with a life-limiting condition in the 
hospital based estimates have risen from 
4,334 (2003/4) to 6,661 (2013/14). The 
absolute numbers of children and young 
people with a life-limiting condition in the 
complete estimates have risen from 12,039 
(2009/10) to 15,404 (2013/14).
Age
Prevalence decreased by age group with the 
highest prevalence in the under 1 age group 
with hospital-based prevalence 163.0 (95% 
CI 157.7-168.3) per 10000 population and 
complete prevalence 192.1 (95% CI 186.3-
197.8) per 10000 population in 2013/14 
(Figure 3). 
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Prevalence in the under 1 age group was steady 
over the period but prevalence increased for all 
other age groups over the period from 2003/4 
to 2013/14. 
Gender
Prevalence was significantly higher for males 
than for females in all years in both the hospital-
based prevalence estimates and the complete 
prevalence estimates (e.g. in 2013/14 hospital-
based prevalence for males was 45.1 (95% CI 
44.4-45.8) per 10000 population compared to 
37.5 (95% CI 36.8-38.2) for females; complete 
prevalence was 102.0 (95% CI 100.9-103.1) per 
10000 population for males compared to 89.2 
(95% CI 88.2-90.3) for females (Figure 4)). 
Diagnoses
The diagnostic group with the highest 
prevalence was congenital anomalies followed 
by oncology and neurology diagnoses 
(2013/14 hospital-based prevalence per 10000 
population: congenital 15.5 (95% CI 15.2-15.9), 
oncology 6.3 (95% CI 6.1-6.5), neurology 
6.6 (95% CI 6.4-6.8); 2013/14 complete 
prevalence per 10000 population: congenital 
34.3 (95% CI 33.8-34.7), oncology 13.8 (95% 
CI 13.5-14.1), neurology 12.7 (95% CI 12.4-13.0) 
(Figure 5)). 
Health Board
The prevalence of children and young people 
with life-limiting conditions is rising in all the 
Health Boards in Scotland over the period of 
this study (Figure 6). The findings of this report 
apply to all Health Board areas however, due 
to small numbers and therefore fluctuating 
prevalence, data from the Western Isles, 
Orkney and Shetland Health Boards could not 
be displayed in this figure.
The evidence on stage of condition
The four stages of a condition; stable, unstable, 
deteriorating and dying have been used 
previously in the independent review of 
Palliative Care Funding in England (PCFR)
(Hughes-Hallet et al., 2011). These stages /
phases of illness were the main criteria 
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FIGURE 4: Hospital-based and complete prevalence of life-limiting conditions by gender among children 
and young people (aged 0-25 years) in Scotland for financial years 2003/4 – 2013/14 .  
Shaded regions indicate 95% confidence interval .
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FIGURE 5: Hospital-based and complete prevalence of life-limiting conditions by diagnostic group 
among children and young people (aged 0-25 years) in Scotland for financial years 2003/4 – 2013/14 . 
Shaded regions indicate 95% confidence interval .
identified which shaped the palliative care 
needs of individuals in the PCFR and from 
which the palliative care currencies were 
developed. In this study the stages of condition 
were defined via key transitions in use of 
health services (Figure 7). 
Each year 14-19% of these children and young 
people with a life-limiting condition were 
either unstable (12-15%), deteriorating (1.6-
2.2%) or dying (1.1-1.6%) (Figure 8). 
Over the five year period studied, the 
proportion of individuals stable for the whole 
year increased from 80.8% (95% CI 80.5-
81.2%; 9729 individuals) to 85.7% (95% CI 
85.4-86.0%; 13203 individuals) (Figure 8). 
The unstable proportion dropped from 15.4% 
(95% CI 15.1-15.8%; 1857 individuals) to 11.6% 
(95% CI 11.3%-11.8% 1783 individuals); the 
deteriorating proportion dropped from 2.2% 
(95% CI 2.0-2.3%; 262 individuals) to 1.7% 
(95% CI 1.5-1.8%; 254 individuals); the dying 
proportion dropped from 1.6% (95% CI 1.5-
1.7%; 191 individuals) to 1.1% (95% CI 1.0-1.1%; 
164 individuals) (Figure 8).
Diagnoses
Those individuals with a perinatal life-limiting 
condition were most likely to be stable 
(2013/14: 93.5%), followed by those with 
congenital (2013/14: 87.6%) and circulatory 
conditions (2013/14: 89.6%) (Figure 9). Those 
with gastrointestinal diagnoses were least 
likely to be stable (2013/14: 69.6%) and were 
also most likely to be dying (2013/14: 3.4%). 
Individuals with respiratory conditions were 
most likely to be deteriorating in most years 
(2009/10:4.5%).
The evidence on deaths
The average number of deaths in Scotland 
each year in children and young people with a 
life-limiting condition was 195 but there was a 
decline in the number of deaths per year over 
the study period (from 208 in 2004/5 to 188 
in 2012/13). The numbers of deaths per year 
varied by age group with the largest number in 
the under 1 year age group (mean 56) followed 
by the 21-25 year olds (mean 40) and 16-20 
years (mean 36) (Figure 10).
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FIGURE 8: Proportions of total children and young people with a life-limiting condition in Scotland at 
each of four stages of condition in financial years 2009/10 – 2013/14 .  
Shaded regions indicate 95% confidence interval .
Place of death
Overall 73.0 % of deaths were in hospital, 
5.6% hospice and 21.4% home. Again 
variation by age was seen with 90.2% of the 
under 1 age group dying in hospital (Figure 11).
The increasing prevalence of children and 
young people with a life-limiting condition in 
Scotland is similar to the results from previous 
research from England (Fraser et al., 2012). 
The lack of increase in the prevalence in the 
under 1 age group over the period of this study 
supports the hypothesis that the increase in 
prevalence is due to increased survival times in 
these children and young people rather than an 
increase in incidence. The difference between 
the hospital-based and complete prevalence 
estimates highlight that approximately 50% of 
children and young people with a life-limiting 
condition in Scotland do not have a hospital 
admission in each year. It is important to note 
that the difference between hospital-based 
and complete estimates is present in all the 
diagnostic groups and the individuals who 
do not have a hospital admission varies each 
year. As the methodology used in this study 
only required a life-limiting condition to be 
coded once for each individual it is possible 
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that these prevalence figures include children 
and young people who have had a transient 
life-threatening event but who are no longer 
life-limited.
The absolute numbers of children and young 
people (0-25 years) in Scotland with a life-
limiting condition in 2013/14 ranged from 6661 
(hospital-based estimates) to 15404 (complete 
estimates). 2201 of these children and young 
people were unstable/deteriorating or dying 
during 2013/14. Children’s Hospice Association 
Scotland receives on average around 115 
new referrals each year and they care for 
approximately 380 children and young people 
and their families each year.
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FIGURE 9: Proportions, by diagnostic category, of total children and young people with a life-limiting 
condition in Scotland at each of four stages of condition in financial years 2009/10 – 2013/14 .
Although paediatric palliative care services 
should be involved in the care of children and 
young people with life-limiting conditions early 
in their disease process, end of life care is an 
important component of paediatric palliative 
care services. There were approximately 200 
deaths each year in this cohort of children 
and young people with life-limiting condition. 
Children’s Hospice Association Scotland 
currently cares for approximately 60 children 
and young people who die each year.
It is clear that the potential demand for 
palliative care in the 0-25 year age group 
outstrips the current provision.
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FIGURE 10: Numbers of deaths, by age group, in financial years 2004/5 – 2013/14 among children and 
young people in Scotland identified as having a life-limiting condition .
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FIGURE 11: Place of death, by age group, for total deaths occurring in financial years 2004/5 – 2013/14 
among children and young people in Scotland identified as having a life-limiting condition
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Recommendation 2: 
Children under 1 year of age should be seen as a priority group for 
input from palliative care services
The evidence on prevalence
The highest prevalence was in the under 1 
age group with hospital-based prevalence 
163.0 (95% CI 157.7-168.3) per 10000 
population and complete prevalence 192.1 
(95% CI 186.3-197.8) per 10000 population 
in 2013/14 (Table 1, Figure 3). Prevalence in 
the under 1 age group was steady over the 
study period.
The evidence on stage of condition
Children aged under 1 year were most likely to 
be unstable (2013/14: 21.6%), deteriorating 
(2013/14: 6.7%) or dying (2013/14: 4.5%) and 
least likely to be stable (2013/14: 67.2%) in this 
cohort (Figure 12). 
The evidence on deaths
The average number of deaths in Scotland 
each year in children and young people with 
life-limiting condition was 195 but there was 
a decline in the number of deaths per year 
over the period (from 208 in 2004/5 to 188 
in 2012/13). The numbers of deaths per year 
varied by age group with the largest number 
in the under 1 year age group (mean 56) 
but this did decline slightly during the time 
period of the study (Figure 10).
Children under 1 accounted for 28.7% of all 
deaths in this cohort or 46.8% of the deaths 
in children and young people with life-limiting 
condition in Scotland aged <16 years. 
Place of Death
90.2% of children under 1 year of age with a 
life-limiting condition in Scotland who died 
between 2004/5-2012/13 died in hospital, 
6.6% died at home and 3.2% died in a 
hospice (Figure 11).
The significantly higher prevalence in the 
under 1 age group is similar to previous 
results from England (Fraser et al., 2012). 
The combination of higher prevalence, 
large percentage of these young children 
being unstable, deteriorating or dying in a 
single year and the very high percentage 
currently dying in hospital makes this 
age group a priority for input from 
palliative care services. This input should 
be a combination of direct provision of 
palliative care and training and education 
of professionals working in perinatal, neo-
natal and paediatric settings.
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FIGURE 12: Proportions, by age group, of total children and young people with a life-limiting condition 
in Scotland at each of four stages of condition in financial years 2009/10 – 2013/14 .
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Recommendation 3:
Age specific palliative care services for young people (aged 16-25 
years) with a life-limiting condition in Scotland should be developed
The evidence on prevalence
The hospital-based prevalence estimates 
have risen in the 16-20 year age group from 
18.3 (95% CI 17.6-19.1) per 10000 population 
in 2003/4 to 31.6 (95% CI 30.6-32.6) per 
10000 in 2013/14 (Figure 3). The complete 
prevalence estimates for the 16-20 year age 
group have risen from 53.8 (95%CI 52.6-
55.1) per 10000 in 2009/10 to 73.3 (95%CI 
71.8-74.8) in 2013/14.
The hospital-based prevalence estimates 
have risen in the 21-25 year age group from 
15.2 (95% CI 14.5-15.9) per 10000 population 
in 2003/4 to 24.3 (95% CI 23.5-25.1) per 
10000 in 2013/14 (Figure 3). The complete 
prevalence estimates for the 21-25 year age 
group have risen from 58.7 (95%CI 57.4-
60.0) per 10000 in 2009/10 to 72.5 (95%CI 
71.1-73.9) in 2013/14.
Diagnoses
Although congenital anomalies had the 
highest prevalence in all of the younger age 
groups, oncology diagnoses became the 
most prevalent diagnosis by 21-25 years 
(2013/14 hospital based prevalence per 10 000 
population: oncology 5.7 (95% CI 5.3-6.1), 
congenital 4.3 (95% CI 4.0-4.6); 2013/14 
complete prevalence per 10000 population: 
oncology 18.8 (95% CI 18.1-19.5), congenital 
13.6 (95% CI 13.0-14.2)). 
The evidence on stage of condition
Although children with a life-limiting condition 
in the under 1 age group were most likely to 
not to be stable in any given year , young 
people with a life-limiting condition in the 16-
20 year and 21-25 year age groups were next 
most likely to experience instability (Figure 12).
The evidence on deaths
There were a mean 195 deaths per year over 
the period, but numbers of deaths varied by 
age group (Figure 10). The mean deaths per 
year for the 16-20 year olds and 21-25 year 
olds were 36 and 40 respectively. The overall 
number of deaths per year declined slightly 
over the period (from 208 in 2004/5 to 188 in 
2012/13) but the deaths in the 16-20 and 21-25 
year age groups remained steady.
Over the period from 2004/5 until 2012/13; 
66.3% of the deaths in the 16-25 year age 
group were in hospital, 28.6% at home and 
5.1% in a hospice (Figure 11). Although CHAS 
continues to offer care to young people up 
to their 21st birthday, at present there is no 
palliative care provider specifically for young 
adults in Scotland. Young adults are a unique 
population with very different needs to 
children and adults and therefore they should 
have services designed to meet those needs.
Paul Ham
pton
Recommendation 4: 
Palliative care services should be able to provide culturally competent 
care to children and young people from ALL ethnic groups .
The evidence on ethnicity
Prevalence of life-limiting conditions was 
highest among individuals of South Asian 
ethnicity (in 2013/2014 hospital-based 
prevalence was 52.1 (95% CI 48.5-55.8) per 
10000 population compared to 38.1 (95% CI 
37.6-38.6) for White cohort members, 37.6 
(95% CI 32.5-42.6) for Black cohort members 
and 35.4 (95% CI 32.6-38.3) for cohort 
members of Other ethnicity (Figure 13). 
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FIGURE 13: Hospital-based prevalence of life-limiting conditions by ethnicity among children and 
young people in Scotland for financial years 2010/11 – 2013/14 .  
Shaded regions indicate 95% confidence interval .
The significantly higher prevalence of 
life-limiting conditions in the South Asian 
population is similar to previous results from 
England (Fraser et al., 2012). Palliative care 
services need to be able to offer culturally 
competent care to children and young 
people with life-limiting conditions from ALL 
ethnic groups.
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Recommendation 5: 
Future development of palliative care services in Scotland should 
ensure that access to services for children and young people from 
areas of high deprivation is prioritised .
were most likely to be unstable (2013/14: 
11.8% compared to 10.4% for the least 
deprived group) (Figure 15).
The higher than expected proportion of 
children and young people with life-limiting 
conditions living in areas of high deprivation 
has been shown previously (Fraser et al., 
2012, Taylor et al., 2010) and in other chronic 
conditions in childhood (Newacheck, 1994). 
Therefore it is important when developing and 
delivering services to ensure that access is 
available for all children and young people with 
life-limiting conditions in Scotland regardless 
of where they live. 
The evidence on deprivation level
There was a linear association with deprivation 
with 25-26% of children and young people 
with life-limiting conditions living in areas of 
highest deprivation and 15-17% of children 
and young people with life-limiting conditions 
who living in the least deprived areas (20% of 
the total population of Scotland live in each 
deprivation category) (Figure 14).
The evidence on stage of condition
There were small differences between children 
and young people with life-limiting conditions 
in the different deprivation categories with the 
least deprived groups most likely to be stable 
(2013/14: 86.9% compared to 85.1% for most 
deprived group) and the most deprived groups 
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FIGURE 15: Proportions, by Scottish Index of Multiple Deprivation (2009) category, of total children 
and young people with a life-limiting condition in Scotland at each of four stages of condition in 
financial years 2009/10 – 2013/14 .
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The psychosocial care and  
support needs of families:  
findings and recommendations
Introduction
The second part of this report sets out the 
recommendations arising from a review of 
qualitative research with children and young 
people, parents and siblings. The review 
comprised two components:
i. A rapid systematic review of studies which 
had obtained the views and experiences of 
children and young people with a diagnosis 
of a life-limiting condition and their families. 
This review excluded those conditions 
where, comparatively, it was envisaged 
that the evidence base would be larger, 
namely: cancer, cystic fibrosis, HIV, chronic 
kidney disease, and cerebral palsy.
ii. A review of existing literature reviews 
which included one or more of the 
conditions excluded from the rapid 
systematic review. 
An overview of the methods can be found in 
Appendix 2. Appendices 3 and 4 provide details 
of the studies included in the review and the 
recommendation(s) which drew on each 
study’s findings. 
The purpose of the review was to identify, 
describe and synthesise evidence on 
families’ needs and experiences in order to 
inform recommendations regarding the 
psychosocial care and support provided 
by palliative care services in Scotland. Five 
recommendations are made based on the 
review’s findings. Primarily, and in line with 
the study objectives, these recommendations 
concern high level principles regarding what 
interventions and support should be provided 
by palliative care services in order to meet 
families’ psychosocial needs, rather than 
specifics of practice. 
Two main, overarching themes emerged from 
the evidence reviewed: the emotional and 
psychological impact of living with a life-
limiting condition, and the ‘extraordinary’ roles 
and responsibilities parents assume. With 
respect to the latter, meeting the child’s care 
needs, and the impact of that on parents’ time 
to fulfil other roles and responsibilities within 
the family, emerged as a dominant issue and 
one where studies consistently report parents 
feel there is insufficient support. 
SECTION 3
M
averick Photo Agency
Two recommendations arise from these 
substantial bodies of evidence:
 n Recommendation 6: Specialist 
psychological and emotional care should be 
available to children and young people and 
all family members. Included in this should 
be support for couples, and support and 
guidance to parents as they respond to the 
emotional needs of their children. Services 
caring for children and young people with 
life-limiting conditions should also find 
ways to provide opportunities for all family 
members to connect with and spend time 
with their ‘peers’.
 n Recommendation 7: Palliative care services 
should consider incorporating domestic 
support to families within their portfolio 
of services. They should also seek ways to 
extend provision of support to parents in 
order to reduce, or provide a break from, 
the caring demands and responsibilities 
placed on parents.
Two further, more specific, recommendations 
arising from the findings of the review are 
also made. The first concerns the role of 
residential provision within the wider portfolio 
of palliative care services: 
 n Recommendation 8: Palliative care 
services in Scotland should continue to 
include specialist residential provision. This 
provision should be extended in light of 
evidence of the size of the population of 
children with life-limiting conditions living 
in Scotland.
The second arises from evidence of children 
and young people’s, parents’ and siblings’ 
experiences of discrimination and social 
exclusion, and the impact this has on their 
emotional well-being and the availability of 
support from informal social networks:
 n Recommendation 9: Palliative care services 
should contribute to or support activities 
which seek to educate and challenge 
societal perceptions of disability.
Finally, the review also identified a discrete 
literature on parents’ psychosocial needs 
during the end of life stage. The topics 
of decision-making, doctor-parent 
communication and bereavement support, 
whilst often appearing as themes or topics 
within the research reviewed, were not 
the focus of this study. There are already 
substantial bodies of evidence on these issues 
and these have been used to develop existing, 
and forthcoming, guidance. However, a further 
set of evidence – consistent across studies – 
emerged concerning parents’ needs as parents 
in the days and hours leading up to their 
child’s death, and the practices which support 
and enable them to parent their child during 
this period. This evidence forms the basis of 
the final recommendation:
 n Recommendation 10: Palliative care 
services, and other services involved in 
providing care at end of life, should examine 
current practices with respect to evidence 
on parents’ psychosocial needs as parents 
in the final stages of their child’s end of life.
Much of the remainder of this section of the 
report presents the evidence underpinning 
these recommendations.
A note about the breadth and quality 
of the evidence
It is important to stress that these 
recommendations are derived solely from 
the available evidence. There are clearly gaps 
in the current evidence base. Therefore the 
recommendations do not, and cannot, cover 
all the potential aspects of psychosocial care 
and support for children and young people 
with life-limiting conditions and their families. 
Overall, the evidence related to parents’ 
psychosocial support needs was quite robust: 
a wide range of life-limiting conditions and 
children’s ages were represented and a 
diverse set of topics or issues explored. The 
evidence base for children and young people 
and siblings was much more limited and 
is dominated by studies of children with 
particular conditions (cancer, heart conditions) 
and who do not have cognitive impairments: 
this constrains the way the evidence can 
be used when identifying implications for 
development and design of palliative care 
services at a more general level. Specific 
examples of evidence gaps are: the religious 
and/or spiritual support needs of children and 
young people; research which has sought to 
describe the lives of children with profound 
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impairments beyond using the accounts of 
parents and other informants; and research 
which has worked directly with children and 
young people moving towards end of life in 
order to identify their needs and experiences.
The issues of access to services and 
care coordination
Before moving on to discuss each 
recommendation and the supporting 
evidence in more detail, it is important to 
raise the issues of access to services and 
care coordination. Not unexpectedly, these 
were both reported and explored in some 
of the studies included in this review. There 
was consistent evidence from these studies 
that difficulties finding out about and 
accessing services and care coordination 
add, sometimes quite significantly, to the 
stresses and demands parents face and their 
sense of isolation (see overview of evidence 
for Recommendation 6 below). Furthermore, 
and in line with wider research on disabled 
young people, the transition to adult 
services emerged as a particularly difficult 
and stressful period, both for parents and 
young people.
Access to services and care coordination 
are clearly issues where differences in 
policy and service organisation are likely 
to influence families’ experiences. None of 
the research identified and included in this 
review was carried out in Scotland. It is for 
this reason we have not developed a specific 
recommendation regarding these issues.
It is, perhaps, useful to note here that 
Scottish Government guidance and 
policy does address the issues of care 
coordination and supporting families 
to identify and access services. Getting 
It Right For Every Child (GIRFEC) – the 
approach set out to improve services for 
children and young people – includes 
the Named Person and Lead Professional 
roles. The role of the Named Person is to 
listen, advise and help a child or young 
person and their family, providing direct 
support or helping them to access other 
services. They can help families address 
their concerns early and prevent situations 
becoming more serious. Lead Professionals 
are for those families using services across 
two or more agencies. The Framework for 
the Delivery of Palliative Care for Children 
and Young People in Scotland (Scottish 
Children and Young People’s Executive 
Group, 2012) identified that the adoption 
of a GIRFEC approach as a key outcome 
for palliative care for babies, children and 
young people in Scotland. Furthermore, 
GIRFEC underpins the recent Children and 
Young People (Scotland) Act 2014 which is 
placing statutory requirements on services 
regarding the way they support children 
with additional needs, including those with 
palliative care needs, and their families.
Recommendation 6:
Specialist psychological and emotional care should be available to 
children and young people and all family members . Included in 
this should be support for couples, and support and guidance to 
parents as they respond to the emotional needs of their children . 
Services caring for children and young people with life-limiting 
conditions should also find ways to provide opportunities for all 
family members to connect with and spend time with their ‘peers’ . 
The emotional experience, and impact 
on emotional well-being, of living with 
a life-limiting condition emerged as a 
significant theme in the review of evidence. 
It was reported in detail by studies which 
specifically explored this issue, and was 
also commonly reported by studies which 
had focused on other aspects of families’ 
experiences. This indicates the prominence 
of this aspect of the experience of living with 
a life-limiting condition. 
Many studies report that parents (and siblings) 
refer to the joy and pleasure they experience 
in their relationship with their child and their 
pride in their child’s response to the difficulties 
they encounter.
Further, the notion of ‘positive growth’ is 
something a number of studies identified 
or investigated in children and young 
people, parents and/or siblings. ‘Positive 
growth’ refers to the changes or gains which 
individuals regard as positive outcomes of a 
difficult or negative experience. The following 
quote from a young adult illustrates this:
First of all, I see him as my son, whom 
I am very proud of…He really gives so 
much happiness .
(GRAUNGAARD ET AL., 2011, P121)
Yes, my son is amazing . He has taught 
me everything .  
(ZIERHUT AND BARTELS, 2012, P51)
However, these positive emotional 
experiences or outcomes occur in parallel with 
a range of difficult and distressing emotions 
which, at times, can be felt most acutely:
Managing difficult and distressing emotions, 
and permanently living in a heightened 
state of emotional strain or stress, take their 
toll, though this may not be recognised or 
acknowledged. Furthermore, in addition to 
managing their own emotional responses, 
parents want to provide the best emotional 
care and support to their children. Based 
on the evidence reviewed, the argument 
for palliative care services to incorporate 
psychological and emotional care is strong. 
In addition, for children and young people, 
parents, and siblings, opportunities to share 
experiences with individuals in similar 
situations is helpful and comforting.  
A lot of people in this world will never 
experience this, and I’m not saying that 
I am glad I had cancer, but I kind of am 
because it’s like, it made me stronger, 
you know…It’s educated me . And it is 
something that I am proud of .
(DURAN, 2013, P190)
I live in a constant state of desperate 
happiness…I try to hang on to every 
happy look and smile, while at the 
same time I live in fear of her death . It 
is possible to have sadness, fear and 
happiness co-existing in you at one time, 
though . I know, because I’m doing it .
(RALLISON AND RAFFIN-BOUCHAL, 2012, P201)
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In addition, some studies reported children 
and young people’s sadness when observing 
the distress of other family members.
Witnessing peers enjoy physical health, 
activities or experiences, or their growth 
towards independence, could prompt 
feelings of anger and jealousy and a ‘longing’ 
to participate. This latter concept crossed 
the boundary with feelings of loss and grief 
which were also reported by some studies.
Studies including children and young 
people with visible physical impairments, 
or who used mobility aids or medical 
technologies outside of the home, 
reported that feelings of ‘difference’, 
embarrassment and social discomfort 
were part of their emotional experiences.
Researchers noted that fatigue and ill-
health affected children and young people’s 
resilience or ability to deal with, or manage 
these emotions. In terms of day to day 
experiences, night-time was often the time 
of day when fears, anxieties and sadness 
were most acutely experienced.
As she [mother] cries, tears also flow in 
my eyes . . .and I feel very sorry for her .  
(LEE AND KIM, 2012, P401)
It sucks to have it and sometimes makes 
me mad, ‘cause when I see my friends 
like ride bikes off jumps and stuff…it’s 
hard to watch them do that .  
(PEHLER AND CRAFT-ROSENBERG, 2009, P 485)
When I’m around people other than the 
ones I know well, I feel uncomfortable 
and embarrassed at myself because of my 
physical disability .
(GAAB ET AL., 2013B, P189)
When I’m about to fall asleep I usually 
think about it…what if something 
happens?
(BRATT ET AL., 2012, P 532)
Peer support consistently emerges as an 
important source of support. 
In seeking ways to implement this 
recommendation, it would appear useful to: 
i) investigate how psychology services work 
in children’s cancer, and other specialist, 
services and the use of clinical psychologists in 
hospices; and ii) review evidence on effective 
ways of providing peer support. Evidence 
on the impact of gender and ethnicity on 
willingness to reveal or share emotional 
distress, and ways of coping, should also 
inform service developments.
Overview of evidence: children and 
young people
Studies of children able to participate in 
verbal interviews revealed the different 
aspects of having a life-limiting condition 
which can arouse negative emotions and/or 
threaten emotional well-being. 
First are the anxieties associated with health 
and prognosis: these were present even when 
understanding of the prognosis did not include 
the life-shortening nature of their condition.
Also, there were the worries and concerns 
experienced by any child or young person 
but which may be exacerbated by having a 
life-limiting condition including: friendship 
difficulties, returning to school after an 
absence, wider relationships with peers, 
schoolwork and future issues, such as 
leaving school, opportunities for intimate or 
sexual relationships and fertility.
Dependency on others, or being aware 
that their condition imposed restrictions 
or demands on other family members, 
caused a range of emotions, particularly 
guilt or frustration.
The thing I worry about most is the, um, 
dying bit . That’s what I don’t like .  
(GAAB ET AL., 2013B, 190)
I felt like s***… .I felt like my brothers and 
sisters missed out on time with my mum .
(GAAB ET AL., 2013B, P189)
In addition, certain times or situations were 
identified as posing a threat to emotional 
well-being. These included:
 n the time around diagnosis; 
 n periods of ill-health or evidence of 
deterioration; 
 n experiencing loss of participation in usual 
occupations and activities due to extended 
period of hospitalisation or ill-health; 
 n experiencing significant changes to the 
body / appearance (e.g. hair loss; scars; 
changes in weight); 
 n the death of a peer;
 n changes to, or changing services; 
 n gaining a fuller understanding of  
their prognosis; 
 n feeling un- or under-informed. 
Some of these events were defined by 
researchers using words such as ‘traumatic’: a 
term which efficiently captures the emotional 
and mental work which may be required to 
recover from, or adapt to, the experience. 
Finally, some studies described the tensions 
that can arise between children and young 
people and their parents. These can arise for 
a number of reasons: managing compliance 
with treatment regimes, perceived parental 
‘over-protectiveness’, returning to higher 
levels of dependency on parents due to 
ill-health, and the transition to greater 
independence during the teenage years and 
into young adulthood.
Overview of evidence: parents
Key conclusions from studies of parents’ 
experiences are set out below. It is 
important to note that these experiences 
may well follow the highly traumatic period 
of the diagnosis or the birth of the child. 
Thus, parents may move into a chronic 
experience of emotional distress and 
dis-ease in an already fragile or depleted 
emotional state.
Parents’ emotional worlds: 
 n Parents can live in a permanent state of 
raised anxiety, dread, and/or sorrow.
 n In addition, parents experience periods 
of intense, and sometimes very mixed, 
emotions.
 n Sources of distress and/or anxiety 
identified include:
 § living with uncertainty;
 § living with the possibility of death;
 § witnessing their child’s physical and/or 
emotional suffering, including suffering 
caused by treatment regimens/protocols;
 § living with loss – loss of ‘what could 
have been’ – and anticipating the loss 
of their child;
 § the reactions and responses of family, 
friends and wider society to their child 
or their situation as parents of a child 
with a life-limiting condition.
 n Being responsible for (often complex and 
life-affecting) treatment protocols can be 
a significant source of emotional strain, 
particularly in the early days of taking on 
this responsibility.
 n Dealings with services often aroused 
feelings of frustration, loneliness and anger.
 n Parents who work may experience 
conflicting emotions around needing to 
work but wanting to spend more time 
with child and family.
 n Ostensibly positive events (for example, 
completing cancer treatment) may be 
associated with heightened levels of anxiety, 
uncertainty and/or a sense of isolation. 
Parents’ responses to, or the impact of, 
emotional strain and distress: 
 n Some parents’ accounts reveal very 
significant levels of emotional distress  
and fragility.
 n Distress and anxiety contributes to 
parents’ experiences of poor quality or 
interrupted sleep.
 n Parents may not recognise, or choose not 
to face, their emotional experiences and 
well-being. 
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 n Hiding anxiety and distress or venting stress 
and frustration can hinder couples’ abilities 
to support each other and may threaten 
their relationship.
 n Mothers and fathers may respond 
differently to the emotional demands and 
strains they face: this can be a source of 
friction, isolation and another source of 
distress in itself.
Overview of evidence: siblings
Evidence from studies which have explored 
the experiences of siblings also reveals the 
potential for a wide-ranging emotional impact. 
Those reported in the studies reviewed are 
summarised in Figure 16.
“It’s an emotional roller coaster . It has 
been in all different levels since the day 
[our child] was diagnosed .”
(CARROLL ET AL., 2012, P6)
“The anxiety I constantly feel never 
subsides . It’s firmly rooted…is 
unrelenting .”
(EATOUGH ET AL., 2013, P1045)
“It’s like a ticking time bomb . You think 
about it every day . You know it’s going 
to happen: you just don’t know when .” 
(ZIERHUT AND BARTELS, 2013, P48)
“Some days we noticed he did not want 
to play, and was more downbeat, more 
sensitive, more introverted, did not 
want to interact… and that distressed us 
much: because we did not know what to 
do to help him .”
(MONTOYA-JUAREZ ET AL., 2013, P722)
“[Transition] was one of the worst years 
in my life . I found it really stressful and 
frustrating… it’s nearly beaten me . It 
just really, really broke me .” 
(KIRK AND FRASER, 2014, P345)
“If I’ve had a really bad day, my instinct 
when he [partner] comes in is to attack: 
I need to scream at somebody and he 
knows . . he does . But it does not make 
for a good relationship .” 
(RODRIGUEZ AND KING, 2009, P9)
In addition, some studies highlighted the 
potential impact on emotional well-being 
caused by loss, or disruption, of normal 
routines, medical crises, and changes in the 
primary caregiver (e.g. father or grandparent 
replacing mother). 
A number of researchers commented on 
the conflicting nature of siblings’ emotional 
responses to having a brother or sister with a 
life-limiting condition and what that entails.  
For example, feeling angry at the same time as 
feeling guilty about that anger. 
Figure 16 sets out what might be regarded as 
negative emotions. In addition, however, some 
studies explored possible positive experiences 
and outcomes for siblings specifically 
associated with having a brother or sister with 
a life-limiting condition. For example, caring 
for, and having particular responsibilities for 
care or household tasks, could engender a 
sense of pleasure or pride. Studies also report 
that the particularly close relationships within 
families could be a source of joy. 
Finally, however, it is important to note that 
some studies reported that siblings may hide 
their emotional responses in order to avoid 
distressing their parents. 
“I try not to make them upset . I silence 
bits of my life . “
(BRENNAN ET AL., 2013, P818)
FIGURE 16: Siblings’ experiences of negative emotions and possible causes
TYPE OF EMOTION SOURCE OR CAUSE 
Guilt Sibling’s own healthiness
Negative feeling towards brother  
or sister
Anger Restrictions on life
Responsibilities associated with 
caring for brother or sister
Other people’s reactions to their 
brother or sister
Anxiety Brother or sister’s health  
and prognosis
Own health and mortality
Sadness Brother or sister’s health  
and prognosis
Anticipating death of brother  
or sister
Lonely Parents pre-occupied with 
 brother or sister
Resentment Responsibilities associated with 
caring for brother or sister
“When I’m at school I’m different . I 
don’t have to worry about things, you 
know . Well, I do, but not as much: I 
can be myself and everything .”
(BRENNAN ET AL., 2013, P819)
“Alone in my room most of the day . 
Sad I couldn’t help [child] . Most of 
my normal days are like this .”
(GAAB ET AL., 2013B, P189) 
“I’m afraid that she is going to get 
sick and nobody will be there .”
(GAAB ET AL., 2013B,P189)
“I feel sad when we are not altogether 
at home . When [child] is at hospital: 
I don’t know if she is really sick and if 
she might die .”
(GAAB ET AL., 2013B, P189)
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Recommendation 7:
Palliative care services should consider incorporating domestic 
support to families within their portfolio of services . They should 
also seek ways to extend provision of support to parents in order 
to reduce, or provide a break from, the caring demands and 
responsibilities placed on parents . 
concept was used to describe the day by day, 
hour by hour, minute by minute experience of 
caring; it was also used to capture its long-
term, or permanent, nature. A number of 
studies reported that parents directly linked 
caring responsibilities to their experiences 
of a lack of time for themselves and/or other 
members of the family, though some studies 
also reported parents contextualised their 
experiences as being those of any parent.
Often co-occurring with the concept of 
the continuous nature of caring was a 
commentary on the pervasiveness of caring. 
Researchers used this and similar terms to 
represent the range of care needs a child may 
have and the way that meeting these care 
needs draws on parents’ physical, mental and 
emotional faculties.
A few studies usefully highlighted how 
parents’ sense of caring responsibility may 
continue even when someone else was 
looking after their child; something that 
studies of parents’ experiences of using short 
break/hospices also report.
“She follows me everywhere .” 
(BRUNS AND SCHREY, 2012, P166)
“Sometimes the days with him are 
particularly intense since the morning 
I wash, dress, prepare his food and 
feed him, I have to keep up with him 
24 hours to 24 . I cannot think of me 
anymore, it’s impossible .” 
(EATOUGH ET AL., 2013, P1044)
“Because there have been long period 
where he is crying every waking minute 
and I feel that I simply can’t stand that 
for a very long time .” 
(GRAUNGAARD ET AL., 2011, P127)
Three of the themes identified in the 
review of evidence provide support for 
this recommendation:
 n parents’ experiences of the caring role;
 n fulfilling domestic tasks;
 n parents’ accounts of physical exhaustion.
Evidence on the way care needs can 
make significant demands on parents’ 
time, attention and physical resources is 
extensive and persuasive. Importantly, all 
the studies reviewed which explored this 
issue also reported that parents felt they did 
not receive enough support with meeting 
their child’s care needs. We also draw on 
two further topics or themes in making the 
case for this recommendation. First, a small 
number of studies revealed the impact of 
caring responsibilities on parents’ abilities to 
complete domestic tasks, something which 
some parents report finding hard to neglect 
even when at the point of utter tiredness. 
Second, conclusions around the importance 
of assisting parents with caring and domestic 
tasks are further supported by parents’ 
accounts of physical exhaustion. 
Parents’ experiences of  
caring responsibilities
A number of studies reviewed explored 
parents’ descriptions of the caring role. 
Caring responsibilities included feeding, 
bathing, toileting, administering treatments 
and medications, comforting, monitoring 
physical health and symptoms, physiotherapy, 
washing, entertaining or keeping occupied, 
watching over to ensure safety in and outside 
of the home, supporting or enabling mobility 
and communication. 
The notion of caring being a continuous 
responsibility was a common theme. This 
Research which looked at experiences of some 
sort of short-break service were very rich in 
parents’ accounts of the pervasiveness of care 
demands, with the break from these demands 
highlighting to parents the ‘extraordinary’ 
nature of their lives as a parent of a child with 
a life-limiting condition. 
The concept of the pervasiveness of caring 
was also used when describing the impact of 
meeting these care needs on other aspects 
of the parent’s and family’s life including 
parents’ physical and mental health, parents’ 
ability to fulfil other roles and spend time 
with other family members and the ability 
of families to enjoy ‘everyday’ family 
experiences and activities.
“You never really get a break, you never 
get a break from the weight of the 
responsibility… It is there and it remains 
present whether you are with your child 
or not . And to not acknowledge that is 
to deny part of yourself .”
(RALLISON AND RAFFIN-BOUCHAL,  
2013, P200) 
“Just taking care of her takes a lot .  
Just travelling with her, with the 
wheelchair, with the pump, dealing with 
all this stuff . Not to do that: it’s respite 
in itself .”
(CHAMPAGNE AND MONGEAU, 2012, P247)
“That’s what’s important when he’s in 
respite: I don’t have to stick to a schedule .”
(CHAMPAGNE AND MONGEAU, 2012, P247)
“When she went [to a short break 
facility], I had a chance to catch up a bit 
more on my sleep . I went back to bed, 
and I went back to sleep, and got some 
of my strength back .”
(CHAMPAGNE AND MONGEAU, 2012, P247)
Keeping up with domestic and other 
household tasks
The issue of managing household tasks was 
explored and reported on in a small number of 
the studies reviewed. The multiple demands 
on parents’ time was identified as impacting 
on their ability to keep up with domestic and 
other household tasks. Importantly, this 
experience was reported by mothers and 
fathers; something which, it could be argued, 
serves to highlight the range of tasks required 
in looking after and maintaining the home.
A couple of studies (of mothers only) suggest 
parents may respond differently to this. Both 
report some mothers accepted the situation 
and adjusted their expectations down to what 
they felt was acceptable. 
For some, however, keeping up with 
household chores was important to parents’ 
sense of control, or an untidy or unclean (by 
their standards) home environment was, in 
itself, an additional source of stress. Indeed, 
it is interesting that studies which have 
explored parents’ experiences of short-term 
care have observed that some mothers 
use the break from caring to catch up on 
housework. The final source of evidence on 
this theme comes from studies of siblings 
where a number of studies report that helping 
out with domestic duties was one of the roles 
siblings may assume. 
Parents’ accounts of physical 
exhaustion
Physical exhaustion was ascribed to the 
demands of fulfilling significant levels of 
caring responsibilities alongside other roles 
and responsibilities, such as domestic and 
other household management tasks, as well 
as desire to make time for siblings and wider 
family life:
“The house isn’t always clean but 
everyone is fed and comfortable .”
(BRUNS AND SCHREY, 2012, P166)
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There is also evidence that there are, 
potentially, also multiple causes of insufficient, 
disturbed sleep or poor quality sleep. Night-
time care requirements and a sub-conscious 
‘listening out’ for the child or equipment alarms 
were both potential sources for parents’ 
sleep to be affected. For parents whose 
sleep was interrupted or disturbed by caring 
responsibilities, an opportunity to catch up on 
sleep was consistently identified as a benefit of 
short-term breaks.
In addition, parents may choose to reduce the 
time they sleep because of a desire to ensure 
domestic and other tasks were properly 
attended to – something which some parents 
reported finding helpful in terms of a sense 
of control and feeling they were fulfilling their 
role, or desire, to care for and nurture the 
whole family.
“… at the moment it’s mere survival … 
it’s a big problem that we are always  
so tired…” 
(GRAUNGAARD ET AL., 2011, P122)
“And you keep going, but your body is 
giving you signals and you don’t listen to 
it . But I don’t have it in me anymore . I 
do it because I have no choice . But it is 
hard, you know . You get older and you 
don’t have that energy anymore .”
(DAVIES ET AL., 2011, P37)
“I could switch off and not sleep with 
one eye open all night . I could get a 
good night’s sleep . Because he is on a 
ventilator machine your mind is always 
on it and you don’t want to get into a 
deep sleep because you are worried that 
you might not hear it [alarm], so it is not 
a proper sleep I get at night times .”
(KIRK AND PRITCHARD, 2012, P35)
“I found that if I want to get things done, 
my only real option is to sleep less . I 
have to stay up late or get up early .”
(BRUNS AND SCHREY, 2012, P166)
Recommendation 8: 
Palliative care services in Scotland should continue to include 
specialist residential provision . This provision should be extended 
in light of evidence of the size of the population of children with 
life-limiting conditions living in Scotland . 
Third, for children and young people, a well-
designed residential service means moving 
around is less effortful and restrictive. This can 
be dramatically different to their experiences 
at home.
Fourth, whether or not it is a whole family 
visit, residential services can allow parents and 
siblings to have time together. This serves to 
address parents’ concerns regarding the time 
they have available for other children, and 
the ways family life can be restricted because 
of the care and other needs of the child. The 
outcome of this is less emotional ‘dis-ease’ 
for parents regarding siblings’ well-being and 
quality of life. 
Fifth, for parents, it provides a break from care 
and caring responsibility. Our earlier discussion 
of the evidence informing Recommendation 
7 clearly supports the argument that this is a 
much-needed function of residential palliative 
care services. Importantly, confidence in staff 
is essential to parents’ using, or gaining the 
most from, this provision. The health and 
“I hate being out in public with my 
wheelchair because I see people that 
I know and sometimes they treat me 
differently and they have no idea what 
I’m going through .”
(GAAB ET AL., 2013B, 190)
“…two wheelchairs can race down the 
corridor side-by-side! And it’s easy for 
me to move from room to room .”
(SWALLOW ET AL., 2012, P263)
“It’s good to know we can enjoy ourselves 
like a family, but he can enjoy himself 
too . I think that’s the biggest thing .”
(CHAMPAGNE AND MONGEAU, 2012, P 249) 
Evidence from the studies which explored 
children and young people’s, parents’ and 
siblings’ experiences of using residential short-
break services suggests that these are positive 
and valued aspects of families’ lives and an 
important element of the care and support 
families receive.
The findings of these studies, together with 
evidence from research which has explored 
the experiences of living with a life-limiting 
condition more widely, highlight the particular 
benefits residential provision can offer. 
First, it provides opportunities for peer 
support between children and young people, 
parents and siblings. Of the studies exploring 
this issue, the chance to spend time with 
others going through the same situation 
and experiences was consistently reported 
as being valued and desired by children and 
young people and parents. 
Second, for all family members, particularly 
children and young people, residential 
services are an environment where illness 
and impairment is the ‘majority experience’, 
thus offering a time of feeling ‘normal’ rather 
than ‘different’. Across the studies reviewed, 
experiences of discrimination, negative or 
unhelpful attitudes from members of the 
public were reported by children and young 
people, parents and siblings. Furthermore, as 
reported earlier, some children and young 
people described feeling uncomfortable or 
embarrassed when out and about. 
“It’s a break and you get to see each other . 
With our short life expectancy we don’t 
see each other enough, so they are really 
precious to me .”
(KIRK AND PRITCHARD, 2012, P36)
Paul Ham
pton
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nursing care skills and expertise of staff were 
critical to parents’ feeling confident about 
handing over the care of their child. In addition 
was a desire that the child also benefited from 
the change in carer.
Finally, residential care provides parents 
with an opportunity for sleep and 
physical recuperation. Again, as reported 
in the evidence presented to support 
Recommendation 7, physical exhaustion and 
sleep deprivation are two outcomes of the 
‘extraordinary’ roles and responsibilities they 
may assume as a parent of child with a life-
limiting condition.
“They pay more attention to new 
medications, hours, diets; everything is 
very, very well monitored”
(CHAMPAGNE AND MONGEAU, 2012,P249)
“It is reassuring for us that he is happy, 
and that he is enjoying himself as much 
as we are . That has an enormous effect 
on our state of mind .”
(CHAMPAGNE AND MONGEAU, 2012,P249)
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Recommendation 9: 
Palliative care services should contribute to or support activities 
which seek to educate and challenge societal perceptions of 
impairment and disability .
Many children with life-limiting conditions 
have physical, learning and/or sensory 
impairments. At a community or societal level, 
therefore, there is the potential for children’s 
palliative care services to contribute in some 
way to educating and challenging societal 
perceptions of impairment and disability. 
This recommendation arises from the findings 
across a number of studies that children and 
young people, parents and siblings experience 
social exclusion, discrimination and negative 
attitudes because of their impairments, or fear 
such experiences happening if they divulge 
their diagnosis. Findings from the studies 
reviewed indicate that these experiences 
may be encountered at school, in local 
communities and within the extended family. 
Such experiences were consistently associated 
with emotional distress and a sense of 
exclusion and social isolation. They added to 
the emotional load of living with a life-limiting 
condition. For parents and siblings, observing 
the child or young person with a life-limiting 
condition experience exclusion and negative 
attitudes was an additional source of distress 
and angst. 
“I don’t think others fully understand: 
my brain is the same as other people . It’s 
just my physical body is different… At 
school they say mean things .”
(GAAB ET AL., 2013B, P190)
“I get angry ‘cause people look at 
[brother/sister] differently . I get annoyed 
when classmates make fun of disabled 
people .”
(GAAB ET AL., 2013B, P190)
“Everyone starts pulling away from you 
too because they are afraid .”
(EATOUGH ET AL., 2013, P1045)
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Recommendation 10: 
Palliative care services, and other services involved in providing 
care at end of life, should examine current practices with respect to 
evidence on parents’ psychosocial needs as parents at their child’s 
end of life .
This final recommendation draws on findings 
from studies which explored parents’ 
experiences of their child’s death. Whilst only a 
few studies were identified which explored this 
topic, they do represent experiences of end of 
life across the entire age range, from perinatal 
death forwards. In addition the findings across 
studies are consistent. A key theme emerging 
from the findings of these studies, and which 
has informed the above recommendation, was 
parents’ need to continue to be parents to their 
child during the final days and hours of their 
child’s life. Yet medical crises and intensive 
care settings can restrict this. It would be fair 
to argue that supporting and enabling mothers 
and fathers to be parents during this period 
will also yield positive outcomes for the child. 
The evidence which informed this 
recommendation draws on the research 
with bereaved parents. It is worth noting 
that in these studies parents made a 
connection between their satisfaction with 
the opportunities they had to continue to be 
their child’s parent, with their views about 
the quality of their child’s death and their 
subsequent adjustment and acceptance of 
their child’s death. 
The wider context for parents’ specific needs 
at end of life is the evidence that parents have 
a very strong, sometimes consuming, desire 
to provide the very best for their child. This 
motivates and energises parents on a day 
to day basis, and these feelings are likely to 
become more acute when parents become 
aware their child’s life is drawing to a close.
“I do not want to be thinking after he has 
gone, “Well, I wish I had done this and 
I wish I had done that”…because you 
cannot change things then . …So as long 
as I know that I have given him the best 
quality of life he could have possibly had, 
then I have nothing to reproach myself 
for later .”
(RODRIGUEZ AND KING, 2009, P9)
Finally, as noted earlier, other parental roles 
during the end of life stage – particularly 
decision-making – were not within the scope 
of the evidence review. 
Parents’ desires to parent during the 
end of life phase: overview of evidence
i. Parents reported wanting choice and 
control over the extent to which they 
maintained their parental role in terms of 
meeting the child’s care needs through 
to the point of death. Bereaved parents’ 
experiences in neo-natal units also stress 
the importance of this experience, even 
though their role had been transitory. 
Appropriately supported, the final act of 
caregiving could be a helpful experience.
ii. Parents wanted to be able to touch and 
hold their child in order to offer emotional 
comfort to their child and/or to comfort 
themselves. This was regarded as a 
fundamental element of the role, and right, 
as a mother or father. It extended beyond 
the moment of death.
“The nurse helped us bathe her and dress 
her …we will remember that time fondly . 
It is the only chance we got to really feel 
like her parents .”
(BRANCHETT AND STRETTON, 2012, P42)
“Sometimes I was told not to touch her 
and this was very painful . Before I could 
change her and cuddle her – the typical 
things you do with a baby . Here [PICU] 
I felt a distance between me and her to 
avoid medical complications .”
(LAMIANI ET AL., 2013, P1337) 
iii. The opportunity for private times with 
their child was a third aspect of what 
parents desired during their child’s end 
of life. Parents described a desire for time 
as a family, for intimacy and quiet. This 
was not just with respect to the moments 
around their child’s death but as a wider 
feature of the days and hours leading up 
to that moment.
iv. Finally, three of the studies which 
contributed to this recommendation offered 
evidence on ethnic or cultural influences 
on parents’ wishes and desires during this 
period. Three issues emerge:
 § There is evidence that there may be 
differences between ethnic groups in 
terms of the extent to which treatments 
and interventions are pursued. The 
researchers note that the transition from 
active management to palliative care 
may be particularly challenging for some 
ethnic groups. 
 § Members of some minority groups may 
be more likely to feel dis-empowered to 
express their wishes and desires.
 § Inadequate provision of interpreters risks 
parents’ wishes and desires not being 
understood or fulfilled. 
“The fact that they called us when [child] 
was already dead was horrible… .not 
being able to be there in that moment 
was devastating … .holding him and 
saying ‘goodbye’ . That time I was almost 
angry . I understand that you [doctors] 
have to do everything possible, but the 
son is mine, isn’t he?”
(LAMIANI ET AL., 2013, P1340)
“I think the most important thing to 
me was that I got to hold him and sit 
with him in a private room and I wasn’t 
rushed into anything .”
(BRANCHETT AND STRETTON, 2012, P42)
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Concluding Comments
The purpose of the ChiSP study was to generate evidence to support the planning and delivery 
of paediatric palliative care in Scotland. It sought to identify the number of children and young 
people with a life-limiting condition living in Scotland, and to describe this population in 
terms of age, diagnosis, geographic location and ethnicity. A further aim was to describe this 
population in terms of the stage of their condition; that is stable, unstable, deteriorating or 
dying. Its final objective was to identify and describe the psychosocial care and support needs of 
these children and young people, and of their families. In terms of service planning, these are all 
key areas of evidence. 
A mixed-method study design, comprising two workstreams, was used to achieve these aims. 
First, analysis of existing administrative and health service datasets was used to generate detailed 
information about the population of children and young people with life-limiting conditions 
in Scotland. The findings from this work are presented in Section 2 of this report. The second 
element of the study was a review of research with children and young people with a life-limiting 
condition, their parents and/or siblings which explored or identified their psychosocial support 
needs. The findings from this evidence review are set out in Section 3.  
On the basis of the findings of these two workstreams, ten high level recommendations have been 
made. The first five recommendations arise from the epidemiological work (workstream 1) and 
draw implications from the evidence regarding the nature of the population of children and young 
people with life-limiting conditions living in Scotland. The remainder of the recommendations 
are based on the findings of the review of evidence on psychosocial care and support needs 
(workstream 2). They are therefore concerned with the types of psychosocial care and support 
which should fall within a portfolio of palliative care services for children and young people and 
their families.  
It is important to note that these recommendations do not address all the evidence needs of those 
involved in planning paediatric palliative care in Scotland. As noted in Appendices 1 and 2, and 
discussed in the earlier sections of this report, there were limitations to the data available for both 
workstreams. This inevitably limits the detail of, and the topics covered in, the recommendations’. 
Nevertheless, we hope this report will prove a useful resource to all organisations in Scotland 
who have a responsibility for children and young people with life-limiting conditions, and/or are 
involved in the planning and delivery of paediatric palliative care.
Finally, as is typically the case at the end of a study, a number of topics or issues emerge as 
potential areas for future research. In terms of the specific recommendations made in this report, 
certainly monitoring and robust evaluation of any changes to the provision, design or content of 
services would be very useful. To this end, it would be helpful to introduce systems by which this 
can be achieved from the outset which should include high quality data collection. At a broader 
level, a prospective cohort study of children and young people with life-limiting conditions 
and their families could provide valuable evidence of their use of healthcare, experience of 
transition(s) and much needed evidence on the physical and mental health of parents and carers.
SECTION 4
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APPENDIX 1
Methods for the quantitative analyses 
of linked healthcare data workstream
Definition of life-limiting 
conditions
A previously developed (Fraser et al., 2011, 
Fraser et al., 2012) list of ICD10 (International 
Classification of Diseases, 10th edition (World 
Health Organisation, 1992)) codes that 
constituted the conditions of interest was 
utilised to identify individuals with a life-
limiting condition. Further refinement of this 
coding framework was undertaken; three 
ICD10 diagnostic codes (Q74.8, Q44.5 and 
F80.3) used to identify individuals with a 
life-limiting condition were omitted as no 
individuals with these codes were known to 
have died during the study period (Table 2).
Population data
Population at risk was determined from 
mid-year estimates by age and gender 
derived from census data (National Records 
of Scotland, 2015). These estimates were not 
available split by ethnic group therefore the 
2011 census population was used to determine 
prevalence by ethnicity.
Datasets used
Routinely collected NHS data were used 
(Figure 1). The study cohort was identified 
by searching the Scottish Morbidity Record 
Inpatient activity database (SMR01) and 
Scottish Birth Records (SBR) for individuals 
resident in Scotland, aged 0-25 years, with 
any of the life-limiting condition indicative 
ICD10 codes listed in any record from 1 April 
2003 to 30 March 2014 (financial years 
2003/4 to 2013/14). Extracts were then made 
for the identified individuals from the following 
data sources:
 n Scottish Birth Records (SBR)
 n Scottish Inpatients Episodes (SMR01)
 n Scottish Outpatient Dataset (SMR00)
 n Scottish Cancer Registry (SMR06)
 n GRO Death registration data
 n Scottish Community Prescribing data 
(available from 2009/10)
 n UK Paediatric Intensive Care Audit Network 
(PICANet) (available from 2007/8)
The SBR contained records of births in Scotland 
and associated neonatal care episodes with 
diagnoses. SMR01 contained all inpatient 
episodes occurring in hospitals in Scotland, 
with patient demographics and diagnoses. 
The PICANet data contained demographic and 
clinical information on episodes involving 
an admission to a PICU in the UK (Paediatric 
Intensive Care Audit, 2015). Community 
prescribing data contained records of 
prescriptions dispensed outside of hospitals 
in Scotland and patient demographics. The 
cancer registry contained date(s) of diagnosis 
with cancer, patient demographics and, if 
occurring, deaths. Death registration data 
contained date of death and diagnostic codes. 
SBR, SMR01 and the community prescribing 
data were used to determine prevalence and 
the other datasets were used to complete 
demographics and to determine date of death 
(Figure 1).
Access to the NSS Scotland data was given 
by the Privacy Advisory Committee (ref 
number: XRB14010) and the linkage of the 
PICANet data to the NSS Scotland data was 
approved by the Health Research Authority. All 
analyses took place within the NHS National 
Services Scotland eDRIS Safe Haven secure 
environment (Information Services Division, 
2015). The results presented here underwent 
disclosure control before release (Information 
Services Division, 2012).
The numbers of referrals and deaths per 
year to Children’s Hospice Association 
Scotland were provided by Children’s Hospice 
Association Scotland.
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A17 B20-B24 C00-C97 E31.0 E84 I21 K55.0 N17 P10.1 Q00.0 Q44.2 H11.1
A81.0 D56.1 D33 E34.8 J84.1 I27.0 K55.9 N18 P11.2 Q01 Q44.7 H49.8
A81.1 D61.0 D43 E70.2 J96 I42 K72 N19 P21.0 Q03.1 Q60.1 H35.5
F84.2 D61.9 D44.4 E71 J98.4 I61.3 K74 N25.8 P28.5 Q03.9 Q60.6 M31.3
G10 D70 D48 E72 I81 K76.5 P29.0 Q04.0 Q61.4 M32.1
G11.1 D76.1 E74 K86.8 P29.3 Q04.2 Q61.9 M89.5
G11.3 D81 E75 P35.0 Q04.3 Q64.2 T86.0
G12 D82.1 E76 P35.1 Q04.4 Q74.3 T86.2
G20 D83 E77 P35.8 Q04.6 Q75.0 Z51.5
G23.0 D89.1 E79.1 P37.1 Q04.9 Q77.2
G23.8 E83.0 P52.4 Q07.0 Q77.3
G31.8 E88.0 P52.5 Q20.0 Q77.4
G31.9 E88.1 P52.9 Q20.3 Q78.0
G35 P83.2 Q20.4 Q78.5
G40.4 P91.2 Q20.6 Q79.2
G40.5 P91.6 Q20.8 Q79.3
G60.0 P96.0 Q21.3 Q80.4
G60.1 Q23.2 Q81
G70.2 Q21.8 Q82.1
G70.9 Q22.0 Q82.4
G71.0 Q22.1 Q85.8
G71.1 Q22.4 Q86.0
G71.2 Q22.5 Q87.0
G71.3 Q22.6 Q87.1
G80.0 Q23.0 Q87.2
G80.8 Q23.4 Q87.8
G82.3 Q23.9 Q91
G82.4 Q25.4 Q92.0
G82.5 Q25.6 Q92.1
G93.4 Q26.2 Q92.4
G93.6 Q26.4 Q92.7
G93.7 Q26.8 Q92.8
Q28.2 Q93.2
Q32.1 Q93.3
Q33.6 Q93.4
Q39.6 Q93.5
Q41.0 Q93.8
Q41.9 Q95.2
Q43.7
TABLE 2: ICD-10 diagnostic coding framework used to identify children and young people in Scotland with 
a life-limiting condition . Conditions were categorised in eleven diagnostic groups .
Age
Date of birth was assigned as the most 
commonly recorded date. Each individual was 
assigned an age in each financial year based 
on age at the start of the first episode (in 
SMR01 and SBR) in that financial year. If there 
was no SMR01 or SBR episode then age at the 
date of the first community prescription in the 
year was used.
Gender
Gender was recorded as male, female or 
not known. The most commonly reported 
gender (excluding not known) was assigned 
to each individual.
Diagnoses
Diagnostic fields in SMR01 and SBR were 
used – there were 6 diagnostic fields in SMR01 
and 32 in SBR. Diagnoses were categorised 
into 11 groups based on ICD10 chapters: 
neurology, haematology, oncology, metabolic, 
respiratory, circulatory, gastrointestinal, 
genitourinary, perinatal, congenital and other 
(Table 2). No attempt was made to prioritise 
diagnoses for an individual and therefore 
individuals may have a life-limiting condition 
in more than one category.
Ethnicity
Ethnicity was determined first by collapsing 
the various ethnicities recorded to four main 
groups: White; South Asian (Indian, Pakistani 
and Bangladeshi); Black; Other (including 
mixed ethnicity). The most commonly 
recorded ethnic group (excluding “not 
known”) was assigned to each individual.
Deprivation
Deprivation category (SIMD2009) was 
assigned based on datazone of residence. The 
five categories were population weighted 
to be equal in size – i.e. 20% of Scotland’s 
population were in each category. Individuals 
were assigned the first deprivation category 
recorded each year.
Date and place of death
Dates of death were contained in death 
registration data, SMR01, the SMR06 and 
PICANet. Dates of death up to one day before 
the beginning of the last known SBR or SMR01 
record were retained to allow for errors or 
delays in registering the beginning of an 
episode; any dates of death earlier than this 
were considered invalid and removed. Dates 
of death were completed first using the death 
registration data and the other sources were 
used to replace only invalid or missing dates 
of death. Place of death was determined 
from the death registration data, as hospital, 
hospice, home, other or unknown. The 
hospice category included the children’s 
hospices operated by CHAS and self-contained 
adult hospices (hospice units within hospitals 
could not be separately identified and were 
recorded in the hospital category).
Analyses
Prevalence
Prevalence figures were estimated using 
two criteria. For “hospital-based prevalence” 
(Fraser et al., 2012) individuals were counted 
in a given year if they had a life-limiting 
condition and any inpatient hospital episode 
(SBR or SMR01) in that year while aged 0-25 
years. Under the second criteria (“complete 
prevalence”), all individuals counted using 
the first set of criteria were included and, in 
addition, individuals were counted if they 
appeared in the community prescribing 
records in that year (this indicated that they 
were still alive and resident in Scotland). 
As community prescribing data were only 
available from 2009 onwards, the complete 
prevalence analyses were limited to financial 
years 2009/10 to 2013/14.
Prevalence and 95% confidence intervals 
(CIs) per 10 000 population was calculated 
for each year overall, by age group, gender, 
IMD category, ethnicity and diagnostic group. 
Due to poor recording of ethnicity in earlier 
years and in the community prescription 
records, analyses of prevalence by ethnicity 
were limited to 2010/11 onwards and to only 
hospital based prevalence.
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Number of Deaths
The number of deaths within the cohort 
each financial year was also calculated and 
split by age group. Data on deaths for the 
first (2003/4) and last years (2013/14) were 
excluded due to cohort edge effects.
Stage of Condition
Four stages of condition were defined: stable, 
unstable, deteriorating and dying (Hughes-
Hallet et al., 2011). 
Transitions between stages were defined a 
priority (Figure 7).
Individuals were stable when present and 
not in one of the other three stages. Status 
was analysed by financial year, with the most 
severe stage of condition being recorded.
The percentage of the total population 
of children and young people with a life-
limiting condition in each category per 
year was calculated overall, by age group, 
diagnostic group and deprivation category. 
The denominator for these analyses was the 
number of individuals in the corresponding 
complete prevalence calculations. The 
numbers of cohort members of non-White 
ethnicity was too small for any analyses of 
stage of condition by ethnicity to be disclosed.
Strengths and limitations 
This study used a transparent and repeatable 
methodology utilising high quality 
administrative data. This study has built upon 
previous methodology and refined the ICD10 
coding framework.
There are some limitations. Importantly, 
although data were available from CHAS on 
the numbers of referrals and deaths, this was 
aggregate data and therefore could not be 
linked to the other datasets. Also no data was 
available from the other providers of paediatric 
palliative care in Scotland. Disclosure control 
rules limited the release of some data.
As an individual only required to have a life-
limiting condition ICD 10 code recorded once 
to be included, this methodology may be 
including individuals who have had a life-
threatening event, particularly around the 
time of birth, but this event may have been 
transient and they may no longer be life-
threatened or life-limited.
The stage of conditions definitions were 
based upon clinical knowledge and 
availability of data.
Methods used for the review of 
qualitative evidence
The overarching objective of the review was 
to synthesise evidence on children and young 
people’s, parents’ and siblings experiences 
of living with a life-limiting condition in order 
to identify and describe the psychosocial 
support needs of families who may benefit 
from support from palliative care services. 
The findings of the review were then used 
to develop recommendations regarding the 
design and future development of palliative 
care service for children and young people 
in Scotland. The focus of the review was 
the psychosocial care and support needs of 
families excluding the time of diagnosis (where 
there is extensive evidence and guidance on 
supporting families at this time) and after the 
child’s death. Papers were therefore excluded 
if (a) they only reported data on care and 
support needs at the time of diagnosis; (b) they 
only reported on bereavement support
There were two elements to the review:
 n a rapid systematic review of primary 
research on all life-limiting conditions (just 
under 300 specific diagnoses) with the 
exception of a small number of conditions 
where there is a high volume of research 
on families’ experiences of living with a life-
limiting condition, namely: cancer, cystic 
fibrosis, cerebral palsy, HIV/AIDS, and renal 
disease;
 n a ‘review of reviews’ of research 
representing cancer, cystic fibrosis, cerebral 
palsy, HIV/AIDS, and chronic kidney disease. 
Searches
All searches were restricted to papers 
published in the English language, from OECD 
countries, over the past five years (2009-
14). These restrictions sought to ensure that 
the findings reported in the papers would 
be relevant and broadly transferrable to 
the situation in Scotland. A full report of the 
searches is available (Arber, 2014). 
The searches involved a comprehensive 
and systematic search of published studies 
indexed by three databases: Medline, CIAHNL, 
and Psychinfo. For the rapid systematic review, 
the search string consisted of ‘diagnosis’ + 
‘family member’ + ‘qualitative research’. The 
diagnoses included in the research were 
drawn from a list of life-limiting conditions 
which was used to create the ICD coding 
framework used in workstream 1 (Fraser et al., 
2011).A total of 14,193 papers were identified. 
For the ‘review of reviews’ the search string 
was adapted to ‘condition’ + ‘family’ + 
‘qualitative’ + ‘review’. A total of 3,747 papers 
were identified
Screening and selection
Rapid systematic review
Titles were screened against inclusion and 
exclusion criteria, at which point 13,372 
papers were eliminated. The abstracts of the 
remaining 821 papers were then screened 
independently by two researchers and a 
further 693 papers were excluded. Full texts 
of the remaining 128 papers were retrieved 
and read in detail, at which point a further 74 
papers were excluded. A total of 54 papers 
met the inclusion criteria and were included in 
the review (see Figure 17). Details of the papers 
are set out in Appendix 3. 
Exclusion criteria
 n <50% of the sample had a life-limiting 
condition; 
 n <50% of the sample was diagnosed at age 
18 years or younger; 
 n <50% of the sample was aged 25 years or 
under; 
 n study only included children with cancer in 
remission;
 n study only investigated experiences of 
diagnostic process, bereavement support 
and/or decision-making
 n study only collected quantitative data
APPENDIX 2
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Total number of papers 
identified: 3,747
Include: 644 papers
Screen by title and abstract
Include: 65 papers
Retrieve full papers
Include: 15 papers
Exclude: 3,103 papers
Exclude: 579 papers
Exclude: 50 papers
FIGURE 18: Screening process for the review papers
Total number of papers 
identified: 14, 193
Include: 821 papers
Screen by title and abstract
Include: 128 papers
Retrieve full papers
Include: 54 papers
Based upon 50 studies
Exclude: 13,372 papers
Exclude: 693 papers
Exclude: 74 papers
FIGURE 17: Screening process for the primary research papers The review of reviews 
The screening process followed that outlined 
above for the rapid systematic review. Papers 
were screened against the search terms 
reported, and were included only if: (a) they 
included studies using qualitative research 
methods; (b) information was provided about 
the studies included in the review; and (c) 
method(s) of analysis were reported. A total of 
15 review papers were included in our review 
(see Figure 18). Details of the included papers 
are set out in Appendix 4.
Rapid systematic review: 
research participants
The total number of participants across the 
included studies was: 90 children and young 
people with life-limiting conditions, 599 
mothers (of which, 208 were bereaved), 
233 fathers (63 bereaved), 106 ‘parents’ (46 
bereaved), 49 brothers (12 bereaved), 60 
sisters (13 bereaved), 2 gender unspecified 
siblings, and 40 other family members (13 
bereaved) (see Table 3 below). In total, 1,179 
research participants took part in the studies 
included in the review. Of those, 355 were 
bereaved. 835 children and young people from 
827 families were represented. 
Of the 54 papers, 3 reported research 
conducted solely with children and young 
people, 33 with parents, 2 with siblings, 
4 with children/young people and their 
parents, 1 with children/young people and 
their siblings, one with parents and siblings, 
3 with children/young people, parents and 
siblings, 6 with parents and other family 
members (grandparents, aunts, cousins), and 1 
conducted solely with grandparents (see  
Table 4).
Thus, parents were participants in 47 of the 
54 papers, children and young people in 11 
papers, and siblings in 7 papers. Consequently, 
the parent data was the richest, most wide-
ranging, and diverse with respect to the 
types of life-limiting conditions represented. 
Children and young people with a life-limiting 
condition represented the smallest number 
of research participants. Those who took part 
in research studies were predominantly older 
children and teenagers, those who were not 
‘medically frail’, and those without significant 
cognitive impairments. For further information 
about the ages and diagnoses of participants 
see Appendix 3.
Rapid systematic review: 
countries represented
The 54 papers were based on 50 studies. 16 
of the papers (from 15 studies) were based 
PARTICIPANT GROUP TOTAL 
NUMBER
OF WHICH, 
BEREAVED
Children and young 
people with life-limiting 
conditions 
90 -
Mothers 599 208
Fathers 233 63
‘Parents’ 106 46
Brothers 49 12
Sisters 60 13
‘Siblings’ 2 -
Other family members 40 13
TOTAL 1,179 355
TABLE 3: Total number of research participants 
TABLE 4: Number of papers reporting research 
conducted with each group
POPULATION NO. OF PAPERS 
REPORTING RESEARCH 
CONDUCTED WITH 
THIS POPULATION
Children/young people 
with a life-limiting 
condition
3
Parents 33
Siblings 2
Children/young people 
and parents
4
Children/young people 
and siblings
1
Parents and siblings 1
Children/young people, 
parents and siblings
3
Parents and grandparents, 
cousins, aunts, etc
6
Grandparents 1
TOTAL NO. OF PAPERS 54
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on research conducted in the USA, 12 from 
England, 7 from Canada, 4 (from 3 studies) 
from New Zealand, 3 (from 2 studies) from 
Sweden, and one paper from each of Australia, 
Brazil, Denmark, Iceland, Italy, Korea (South), 
the Netherlands, Spain, and Switzerland. In 
addition, two papers (from one study) were 
based on research conducted in the USA, 
Canada, England and Scotland, and one paper 
was based on research conducted in the 
Netherlands, Italy, Poland and Sweden.
Rapid systematic review: quality 
of the evidence 
The quality of the papers included in the review 
of primary evidence was appraised using 
the methodology checklist for qualitative 
studies published by the National Institute for 
Health and Care Excellence (NICE, 2012). In 
line with the checklist, papers were assessed 
in terms of their execution and reporting of 
the characteristics of the population in the 
sample, the methods, and analysis. Each paper 
was assessed against a range of criteria which 
were then grouped within a sub-category and 
graded ‘good’, ‘mixed’, or ‘poor’. A grade of 
overall quality was then produced: ‘good’ if 
all 3 sub-groups (sample, methods, analysis) 
scored good, ‘good/mixed’ if the paper scored 
good in two sub-groups and mixed in the third, 
‘mixed’ if at least two of the sub-groups were 
scored as mixed, and ‘poor’ if two or more of 
the sub-groups had been graded as poor. Of 
the 54 primary research papers, 26 were rated 
as good, 16 good/mixed, 11 mixed, and 1 poor. 
Studies were not excluded or weighted on the 
basis of the quality assessment.
Analysis
A thematic approach to the analysis was 
taken. Each paper was initially read by two 
members of the research team (BB and NM) 
to identify themes or ‘topic areas’. These 
were informed by the research objectives. 
The identification of themes was an iterative 
process as discussion within the team was 
ongoing. Themes/topic areas on which 
research evidence could be extracted was 
agreed within the team. Each paper was 
then reviewed for evidence on a theme-by-
theme basis. Relevant evidence, including 
study information and verbatim quotes, were 
extracted into distinct ‘topic documents’. Each 
paper was then reviewed again to check that 
all relevant evidence on all identified topics 
had been extracted. Discussion and review of 
the topic areas and the conceptual framework 
in which the evidence and review of that 
evidence was located was ongoing within the 
team. Topic documents were reviewed as a 
whole, across each of the populations (parents, 
children and young people, siblings) to identify 
higher level concepts. Analysis of the higher 
level concepts, and the evidence underpinning 
them, was used to identify and inform the 
recommendations contained in this report. 
Strengths and limitations 
A key strength of the review of primary 
evidence is that it synthesises evidence 
relevant to understanding families’ 
psychosocial care and support needs from a 
large number of life-limiting conditions, many 
of which are rare and have only been included 
in one, or a handful of, studies. The review 
also represented a good range of children’s 
ages. The review is a rapid systematic review 
as there were not the resources for two 
researchers to extract data from each paper. 
The quality of studies was reasonable, though 
weaknesses in terms of selection bias and 
insufficient detail about the data collection 
and/or analytical process are to be noted. 
In terms of the review of reviews, cancer is 
over-represented and the low representation 
of cystic fibrosis, HIV and cerebral palsy in 
the studies taken forward into the review 
is a limitation. However, based on our 
knowledge of UK children’s hospices, it is our 
judgement that children with cerebral palsy 
were represented in studies included in the 
review of primary evidence in studies where 
participants were simply described as having 
a ‘life-limiting condition’ and were recruited 
from children’s hospices. Finally, not all studies 
were systematic reviews, perhaps reflecting 
the relatively recent implementation of this 
methodology with qualitative data. 
Given the resources available, conducting a 
review of primary evidence and a ‘review 
of reviews’ to achieve the study objectives 
appears to have proved a useful approach. 
However, whilst there is a high volume of 
qualitative research on children and young 
people with HIV and cystic fibrosis, it would 
appear there have not been many attempts to 
review and synthesise this evidence in terms 
of psychosocial needs: this was unexpected.
Overall, the evidence reviewed is dominated 
by parents’ accounts. Furthermore, the 
children and young people who took part 
in the studies had neither cognitive nor 
communication impairments. Whilst we did 
extract and use data on parents’ accounts of 
their views of their child’s life for this review, 
this does highlight a need for qualitative 
research which captures and describes 
the worlds of children and young people 
with more severe impairments. Similarly, 
the evidence base for siblings of children 
with life-limiting conditions was relatively 
sparse compared to that for parents’ views 
and experiences. Finally, sampling bias is 
particularly an issue with respect to the 
studies which included children and young 
people or siblings. 
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Description of the review papers
AUTHOR & YEAR LIFE-LIMITING 
CONDITION(S) 
REPRESENTED IN 
THE REVIEW
PERIOD 
COVERED
AUTHOR’S 
DESCRIPTION OF THE 
REVIEW
NO. OF 
PAPERS 
INCLUDED 
IN THE 
REVIEW
RECOMM. 
INFORMED 
BY THE 
REVIEW
Alderfer et al. 2010 Cancer 1997-2008 Systematic review 65 6,7
da Silva et al. 2010 Cancer 1997-2009 Integrative review 14 6,7,8
Duran 2013 Cancer 1975-2010 Narrative synthesis 35 6
Gibbins et al. 2012 Cancer 1998-2010 Systematic review 28 6,7,8,9
Jones et al. 2010 Cancer 1984-2007 Integrative review 53 6,7,8
Lee et al. 2012 Cancer 2000-2010 Metasynthesis 8 6,9
Long & Marsland 
2011
Cancer 1996-2009 Systematic review 71 6,7
Marris et al. 2011 Cancer 1996-2008 Review 18 6,8
Muhammad et al. 
2012
Chronic Kidney 
Disease
1957-2011 Literature review 63 6
Pini et al. 2012 Cancer 1991-2011 Systematic review 22 6,8,9
Pousada et al. 2013 Cerebral Palsy 1996-2011 Systematic review 46 6
Santer et al. 20141 HIV, Cystic Fibrosis 1996-2011 Systematic review 19 6,9
Tjaden et al. 2012 Chronic Kidney 
Disease
1971-2011 Systematic review 17 6,9
Tong et al. 20132 Chronic Kidney 
Disease
1991-2009 Systematic review 14 6,8
Wakefield et al. 2011 Cancer 1979-2009 Review 15 6
 
1 Review also included studies representing children with asthma, diabetes, juvenile arthritis. 
2 Review also included studies representing children with diabetes.
ENDNOTES
1 Papers were only included in the study if more than 50% of the sample were aged 25 years or younger
2 Papers were only included in the study if more than 50% of the sample had a life-limiting condition.
3 Not all the evidence reviewed was taken forward into informing the recommendations set out in this report, hence some cells in this 
column are not populated. This was because, for a small number of themes emerging from the analysis, there was not sufficient or high 
enough quality evidence to be taken forward to inform a recommendation(s).
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